Vynleads, Inc. (VYND) stock
Close on Oct 16, 2026Market cap $7.51MP/E –Yield –
Vynleads, Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. At the latest close the market valued the company at $7.51M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $7.51M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$277.86K
- EPS, diluted
- -$0.01
- Book value per share
- -$0.02
- Diluted shares
- 18M
Trading
- Previous close
- $0.41
- Open
- $0.41
- Day's range
- $0.41 – $0.41
- Volume
- 0
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | VYND | S&P 500 | Difference | VYND per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +1.5% | −1.5 pts | ||
| 3 months | 0.0% | +1.9% | −1.9 pts | ||
| Year to date | +29.7% | +12.8% | +16.9 pts | ||
| 1 year | -18.0% | +16.8% | −34.8 pts | ||
| 3 years | -25.5% | +81.5% | −107.0 pts | -9.3% | +22.0% |
| 5 years | -19.6% | +83.0% | −102.7 pts | -4.3% | +12.8% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
About Vynleads
Services-Personal Services
Vynleads, Inc. is a wellness technology company that develops and operates digital lifestyle programs focused on metabolic health and chronic conditions. The company’s flagship product is Done With Diabetes, an application-based subscription program structured around a 56-day user journey with daily missions, nutritional guidance, recipe recommendations, metric tracking, and community support. The platform integrates an artificial intelligence coaching system known as Dr. Smith AI Coach along with an agentic support architecture. Its primary consumer audience consists of adults diagnosed with type 2 diabetes or prediabetes, as well as individuals pursuing broader metabolic health goals. The company also intends to offer its services to enterprise clients, including self-insured employers, health plans, and healthcare provider groups.
Company profile, executives and historyVynleads stock: common questions
What is Vynleads's stock price?
VYND closed at $0.41 on Oct 16, 2026, up 0.00% on the day.
What is Vynleads's market cap?
Vynleads was worth $7.51M at the close on Oct 16, 2026: the share price times the diluted shares outstanding.
What is VYND's P/E ratio?
Vynleads lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.01), so it has no meaningful P/E ratio.
How much revenue does Vynleads make?
Vynleads reported revenue of $0 for the twelve months to Jun 30, 2026.
Does Vynleads pay a dividend?
No. Vynleads has not paid a cash dividend over the last twelve months.
How has VYND stock performed over the past year?
Including dividends, VYND returned -18.0% over the past year, against +16.8% for the S&P 500.
Who are Vynleads's competitors?
Companies most similar to Vynleads by business, industry and size include WW, DOGP, DLTI, VGES, MRM.
See a number that looks wrong?